The membrane attack complex as an indicator of complement hyperactivation in type 2 diabetes mellitus
https://doi.org/10.14341/2072-0351-6218
Abstract
Aim.
Comparative analysis of the levels of the membrane attack complex (MAC) - an end product of complement activation, and of hemolytic activitiesof C1 and C3 complement components in sera of patients with diabetes mellitus 2 (DM2) and healthy subjects.
Materials and methods.
37 DM2 patients (7 men, 26 women, mean age 58?9 years (M?б) and 37 healthy subjects without a family history of hereditarydiabetes (17 men, 20 women, mean age 52?12 years). Serum MAC levels were measured by ELISA, C1 and C3 hemolytic activities by usingrabbit antibody-sensitized ram erythrocytes and C1, C3-deficient sera.
Results.
Mean values of all measured parameters in DM2 patients were significantly higher than in controls.
Conclusion.
Pathogenesis of DM2 is characterized by hyperactivation of the complement system including both the classical and terminal cascadesand by hyperproduction of its cytotoxic products.
Comparative analysis of the levels of the membrane attack complex (MAC) - an end product of complement activation, and of hemolytic activitiesof C1 and C3 complement components in sera of patients with diabetes mellitus 2 (DM2) and healthy subjects.
Materials and methods.
37 DM2 patients (7 men, 26 women, mean age 58?9 years (M?б) and 37 healthy subjects without a family history of hereditarydiabetes (17 men, 20 women, mean age 52?12 years). Serum MAC levels were measured by ELISA, C1 and C3 hemolytic activities by usingrabbit antibody-sensitized ram erythrocytes and C1, C3-deficient sera.
Results.
Mean values of all measured parameters in DM2 patients were significantly higher than in controls.
Conclusion.
Pathogenesis of DM2 is characterized by hyperactivation of the complement system including both the classical and terminal cascadesand by hyperproduction of its cytotoxic products.
About the Authors
Elina Alexandrovna Arakelova
Institute of Molecular Biology, Erevan
Meri Robertovna Ovsepyan
Institute of Molecular Biology, Erevan
Anna Surenovna Boyadzhyan
Institute of Molecular Biology, Erevan
Arsen Artashesovich Arakelyan
Institute of Molecular Biology, Erevan
Astkhik Artavazdovna Gevorkyan
Armenia Medical Centre, Erevan
Ashot Andreevich Mamikonyan
Armenia Medical Centre, Erevan
References
1. Volankis J.E., Frank M.M. The human complement system in health and disease // Mircel Dekker. - Inc, New York, 1998.
2. Sakamoto M., Fujisawa Y., Nishioka K. Physiologic role of the complement system in host defense, disease, and malnutrition // Nutrition. - 1998. - V. 14 (4). - P. 391-398.
3. Sim R.B., Laich A. Serine proteases of the complement system // BiochemSoc. Trans. - 2000. - V. 28 (5). - P. 545-550.
4. Mollnes T.E., Song W.C., Lambris J.D. Complement in inflammatory tissue damage and disease // Trends Immunol. Today. - 2002. - V. 23 (2). - P. 61-66.
5. Cole D.S., Morgan B.P. Beyond lysis: how complement influences cell fate // Clin. Sci. - 2003. - V.104 (5). - P. 455-466.
6. Nauta A.J., Roos A., Daha M.R. A regulatory role for complement in innate immunity and autoimmunity // Int. Arch. Allergy Immunol. - 2004. - V. 134 (4). - P. 310-323.
7. Handwerger B.S., Fernandes G., Brown D.M. Immune and autoimmune aspects of diabetes mellitus // Hum. Pathol. - 1980. - V. 11 (4). - P. 338-352.
8. Pino S.C., Kruger A.J., Bortell R. The role of innate immune pathways in type 1 diabetes pathogenesis // Curr. Opin. Endocrinol. Diabetes Obes. - 2010. - V. 17 (2). - P. 126-130.
9. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease // Nat. Rev. Immunol. - 2011. - V.11 (2). - P. 98-107. 10. Bariş N., Erdoğan M., Sezer E., Saygili F., Mert Ozgönül A., Turgan N.,
10. Ersöz B. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria // Acta Diabetol. - 2009. - V. 46 (4). - P. 309-316.
11. Huysman E., Mathieu C. Diabetes and peripheral vascular disease // Acta Chir. Belg. - 2009. - V. 109 (5). - P. 587-594.
12. Kaneto H., Matsuoka T.A., Nakatani Y., Kawamori D., Miyatsuka T., Matsuhisa M., Yamasaki Y. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes // J. Mol. Med. - 2005. - V.83 (6). - P. 429-439.
13. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., Karin M. JNK1 in hematopoietically derived cells contributes to dietinduced inflammation and insulin resistance without affecting obesity // Cell Metab. - 2007. - V. 6 (5). - P. 386-397.
14. Овсепян М.Р., Бояджян А.С., Оганесян Л.П., Maмиконян A.A., Геворкян A.A. Активация системы комплемента по классическому и альтернативному пути при длительном течении сахарного диабета 2-готипа // Проблемы эндокринологии (Москва). - 2006 (6). - С. 14-17.
15. Morgan B.P., Daniels R.H., Williams B.D. Measurement of terminal complement complexes in rheumatoid arthritis // Clin. Exp. Immunol. - 1988. - V. 73. - P. 473-478.
16. Watford W.T., Ghio A.J., Wright J.R. Complement-mediated host defense in the lung // Physiol. Lung Cell. Mol. Physiol. - 2000. - V. 279 (5). - P. 790-798.
17. Daha M.R. Purification of complement component / In Doods, A.W. and Sim, R.B. eds: Complement. A practical approach. Oxford University press, Oxford. - 1997. - P. 121-133.
18. Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates / In: Morgan, B.P. ed. Methods in molecular biology. Complement methods and protocols. Humana Press, Totowa, New Jersey. - 2000. - V. 150. - P. 61-71.
19. Rosoklija G.B., Dwork A.J., Younger D.S., Karlikaya G., Latov N., Hays A.P. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy // Acta Neuropathol. - 2000. - V. 99 (1). - P. 55-62.
20. Gerl V.B., Bohl J., Pitz S., Stoffelns B., Pfeiffer N., Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy // Invest Ophthalmol Vis Sci. - 2002. - V.43 (4). - P. 1104-1108.
21. Галстян Г.Р. Метаболические нарушения при сахарном диабете 2 типа и методы их коррекции // Русский медицинский журнал. - 2001. - Т. 9 (24). - С. 1098-1100.
22. DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus // Med. Clin. N. Am. - 2004. - V. 88. - P. 787-835.
23. Ahlqvist E., Ahluwalia T.S., Groop L. Genetics of type 2 diabetes // Clin. Chem. - 2011. - V. 57 (2). - P. 241-254.
24. McMillan D.E. Development of vascular complications in diabetes // Vasc. Med. - 1997. - V. 2 (2). - P. 132-142.
25. UKPDS Group. Intensive blood glucose control with sulphonylureasor insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes // Lancet. - 1998. - V. 352. - P. 837-853.
26. Acosta J., Qin X., Halperin J. Complement and complement regulatory proteins as potential molecular targets for vascular diseases // Curr. Pharm. - 2004. - V. 10 (2). - P. 203-211.
27. Huang Y., Smith C.A., Song H., Morgan B.P., Abagyan R. Tomlinson S. Insights into the human CD59 complement binding interface toward engineering new therapeutics // J. Biol. Chem. - 2005. - V. 280 (40). - P. 34073-34079.
28. Acosta J., Hettinga J., Fluckiger R., Krumrei N., Goldfine A., Angarita L., Halperin J. Molecular basis for a link between complement and the vascular complications of diabetes // Proc. Natl. Acad. Sci. USA. - 2000. - V. 97 (10). - 5450-5455.
29. Qin X., Goldfine A., Krumrei N., Grubissich L., Acosta J., Chorev M., Hays A.P., Halperin J.A. Glycation inactivation of the complement regulatory protein CD59. A possible role in the pathogenesis of the vascular complications of human diabetes // Diabetes. - 2004. - V. 53. - P. 2653-2661.
30. Cheng Y., Gao M. The effect of glycation of CD59 on complementmediated cytolysis // Cell. Mol. Immunol. - 2005. - V. 2 (4). - P. 313-317.
31. Barber A.J., Gardner T.W., Abcouwer S.F. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy // Invest. Ophthalmol. Vis. Sci. - 2011. - V. 52 (2). - P. 1156-1163.
32. Park S.H., Park J.W., Park S.J., Kim K.Y., Chung J.W., Chun M.H., Oh S.J. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina // Diabetologia. - 2003. - V. 46 (9). - P. 1260-1268.
Review
For citations:
Arakelova E.A., Ovsepyan M.R., Boyadzhyan A.S., Arakelyan A.A., Gevorkyan A.A., Mamikonyan A.A. The membrane attack complex as an indicator of complement hyperactivation in type 2 diabetes mellitus. Diabetes mellitus. 2011;14(3):17-20. (In Russ.) https://doi.org/10.14341/2072-0351-6218
Views:
1420
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
